OSOM® Ultra Flu A&B Test

The OSOM Ultra Flu A & B Test

is an in vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens directly from nasal swab, nasopharyngeal swab, and nasopharyngeal aspirate/wash specimens obtained from patients with signs and symptoms of respiratory infection.

Meets the Influenza reclassification requirements for rapid antigen tests

FDA EUA

Yes!

Results

10-15 minutes

Simple

Simple 5 step CLIA-waived procedure with pre-measured extraction buffer for swab samples

Application

Point of care (POC)

Also meets the Influenza reclassification requirements for rapid antigen tests

Detection

 Detect Influenza type A and type B

Tests per Kit

25 Tests (plus 2 extra for external QC)

Sample Type

Nasal swab, nasopharyngeal swab, and nasopharyngeal aspirate/wash

Influenza A

Sensitivity: 89.2% (95% CI:83.0-93.4%)

Specificity: 99.4% (95% CI:80.1-90.9%)

Influenza B

Sensitivity: 86.4% (95% CI:97.7-99.8%)

Specificity: 99.0% (95% CI:97.1-99.7%)

Availability

Immediate – 2 weeks

CDC

Human Influenza Panel Testing

Package Insert

Aspirate

Brochure

CLSI

Procedure

Package Insert

Control

Package Insert

Ultra Flu

Package Insert

Multilingual

FDA Disclaimer

This product has not been FDA cleared or approved, but has been authorized by FDA under an EUA for use by authorized laboratories; this product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

NEED ORDER AND PRODUCT INFORMATION?

We are here to help! Talk to one of our specialists.